West End Advisors, LLC Bristol Myers Squibb CO Transaction History

West End Advisors, LLC

$4.27 Billion
Q3 2025

A detailed history of West End Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West End Advisors, LLC holds 61 shares of BMY stock, worth $2,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 88 30.68%

Holding current value

$2,855

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	SELL	$43.31 - $48.98 $1,169 - $1,322	-27 Reduced 30.68%	61 $2,000
Q2 2025 Jul 23, 2025	BUY	$44.12 - $59.6 $397 - $536	9 Added 11.39%	88 $4,000
Q1 2025 Apr 24, 2025	BUY	$53.9 - $63.11 $2,802 - $3,281	52 Added 192.59%	79 $4,000
Q4 2024 Jan 28, 2025	BUY	$51.92 - $59.94 $207 - $239	4 Added 17.39%	27 $1,000
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $79 - $103	-2 Reduced 8.0%	23 $1,000

Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $322 - $423	-8 Reduced 24.24%	25 $1,000
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $47 - $54	1 Added 3.13%	33 $1,000
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $96 - $115	2 Added 6.67%	32 $1,000
Q3 2023 Oct 19, 2023	BUY	$57.89 - $64.73 $1,736 - $1,941	30 New	30 $1,000
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $197 - $223	3 Added 12.0%	28 $1,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $136 - $162	-2 Reduced 7.41%	25 $1,000
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $0 - $76	1 Added 3.85%	27 $2,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $290 - $319	4 Added 18.18%	26 $2 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $307 - $368	5 Added 29.41%	22 $1.61 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $59 - $69	-1 Reduced 5.56%	17 $1.01 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $1,114 - $1,213	18 New	18 $1.2 Million
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $31.5 Million - $34.9 Million	-706,697 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $3.43 Million - $4.09 Million	76,013 Added 12.05%	706,697 $33.7 Billion
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $3.07 Million - $3.99 Million	-63,063 Reduced 9.09%	630,684 $32.8 Billion
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $1.09 Million - $1.23 Million	-19,770 Reduced 2.77%	693,747 $43.1 Billion
Q2 2018 Jul 26, 2018	BUY	$50.53 - $62.98 $1.75 Million - $2.18 Million	34,634 Added 5.1%	713,517 $39.5 Billion
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $612,741 - $705,389	-10,226 Reduced 1.48%	678,883 $42.9 Billion
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $11.5 Million - $12.5 Million	-191,262 Reduced 21.73%	689,109 $42.2 Billion
Q3 2017 Nov 03, 2017	SELL	$55.23 - $63.74 $2.55 Million - $2.95 Million	-46,250 Reduced 4.99%	880,371 $56.1 Billion
Q2 2017 Aug 09, 2017	BUY	N/A	926,621	926,621 $51.6 Billion

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.

Account

West End Advisors, LLC Bristol Myers Squibb CO Transaction History